A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1997
12/10/1997	EP0811065A1 Antagonists of interleukin-15
12/10/1997	EP0811063A2 Chemokine receptors 88-2b ckr-3] and 88c and their antibodies
12/10/1997	EP0811062A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof
12/10/1997	EP0811061A1 Multiple-tumor aberrant growth genes
12/10/1997	EP0811059A1 Human chemokine beta-11 and human chemokine alpha-1
12/10/1997	EP0811016A1 Synthetic peptide based immunogens for the treatment of allergy
12/10/1997	EP0811013A1 Isolated nonapeptides presented by hla molecules, and uses thereof
12/10/1997	EP0810877A1 Hepatitis b vaccine
12/10/1997	EP0810876A1 Influenza virus subunit conjugates
12/10/1997	EP0810874A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
12/10/1997	EP0810870A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
12/10/1997	EP0638122B1 Cdna sequence of dengue virus serotype 1 (singapore strain)
12/10/1997	EP0567503B1 Pasteurella haemolytica glycoprotease gene
12/10/1997	EP0504335B1 A fibronectin binding peptide
12/10/1997	EP0477201B1 Polymorphism of human platelet membrane glycoprotein iiia and diagnostic application thereof
12/10/1997	CN1167505A Tie-2 ligands, methods of making and uses thereof
12/10/1997	CN1167491A Synthetic IgE membrane anchor peptide immunogens for the treatment of allergy
12/10/1997	CN1167440A Immunotherapeutic stress protein-peptide complexes against cancer
12/10/1997	CN1167146A Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/10/1997	CN1166989A Radio-immunity treatment agent of anti human hepatic cancer monoclone antibody HAb18
12/10/1997	CN1166988A Radio-immunity diagnosis agent of anti human hepatic cancer monoclone antibody HAb18
12/09/1997	US5696238 For production of vaccines
12/09/1997	US5696237 Recombinant antibody-toxin fusion protein
12/09/1997	US5696091 Use of growth factor and antimetabolite combination to prevent or retard secondary cataract formation
12/09/1997	US5696088 Chimeric proteins
12/09/1997	US5696000 Adhesion receptors for pathogenic or opportunistic microorganisms
12/09/1997	US5695995 Neurogenic differentiation (neurod) genes
12/09/1997	US5695994 Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules
12/09/1997	US5695991 A complex between a virus the cell binding receptor of which has been inactivated and an antibody able to interact with specific antigen; antigen has ability to mediate entrance into mammalian cells
12/09/1997	US5695983 Mutant cells; genetic engineering
12/09/1997	US5695957 Polypeptides and DNA encoding same, associated with human malaria parasites
12/09/1997	US5695956 Clostridium perfingens type a enterotoxin toxoid and methods of preparation and use as a vaccine and therapeutic agent
12/09/1997	US5695950 Method of screening for antimitotic compounds using the cdc25 tyrosine phosphatase
12/09/1997	US5695931 Nucleotide sequences coding for a protein with urease activity
12/09/1997	US5695770 Induction of cytotoxic T-lymphocyte responses
12/09/1997	US5695769 Bacterin comprising cell-bound toxoid, immunogenic amount of alkaline-toxoided pasteurella multocida cell-free toxin, carrier for internal administration
12/09/1997	US5695768 Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
12/09/1997	US5695767 Live, attenuated rotavirus which stimulates antibody production
12/09/1997	US5695766 Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
12/09/1997	US5695765 Mutant pseudorabies virus, and vaccines containing the same
12/09/1997	US5695762 Immunodominant sites of HTLV-I envelope protein
12/09/1997	US5695760 Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
12/09/1997	US5695759 An immunoadsorbent comprising a biocompatible solid support having atleast one identified carbohydrate xenoantigen to preformed antibodies attached thereto through biocompatible linker
12/09/1997	US5695758 Hybridoma cells
12/09/1997	US5695755 Peripheralization of hematopoietic stem cells
12/09/1997	CA2135922C Quick-change tool holder with center-height adjustment mechanism
12/04/1997	WO1997045544A1 Antibodies to the ed-b domain of fibronectin, their construction and uses
12/04/1997	WO1997045538A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces
12/04/1997	WO1997045450A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
12/04/1997	WO1997045449A1 Dendritic cell receptor
12/04/1997	WO1997045447A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS
12/04/1997	WO1997045444A1 Ebv ctl epitopes
12/04/1997	WO1997045143A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	WO1997045142A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/04/1997	WO1997045140A1 Concentrated antibody preparation
12/04/1997	WO1997045139A2 Il-12 as an adjuvant for bordetella pertussis vaccines
12/04/1997	WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis
12/04/1997	WO1997045009A2 Long-term shelf preservation by vitrification
12/04/1997	WO1997038689A3 Enteric-coated pharmaceutical compositions of mycophenolate
12/04/1997	CA2256588A1 Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/04/1997	CA2256481A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	CA2256333A1 Long-term shelf preservation by vitrification
12/04/1997	CA2255941A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/04/1997	CA2255927A1 Ebv ctl epitopes
12/04/1997	CA2254983A1 Concentrated antibody preparation
12/03/1997	EP0810435A2 Detectable molecules, method of preparation and use
12/03/1997	EP0810285A2 Mutants of human Interleukin-3
12/03/1997	EP0810283A2 Live attenuated RTX-procucing bacteria of the family Pasteurellaceae
12/03/1997	EP0809705A1 Nucleic acid-containing composition, preparation and use thereof
12/03/1997	EP0809700A1 Papilloma virus-like particles, fusion proteins and process for producing the same
12/03/1997	EP0809699A1 New chemokines expressed in pancreas
12/03/1997	EP0809698A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
12/03/1997	EP0809695A1 Transcription factor - e2f-5
12/03/1997	EP0809656A1 MONOCLONAL ANTIBODY SPECIFIC FOR $g(b)A4 PEPTIDE
12/03/1997	EP0809653A1 Helicobacter pylori antigen
12/03/1997	EP0809517A1 Anti-transforming growth factor-beta gene therapy
12/03/1997	EP0809516A1 Medicinal combination useful for in vivo exogenic transfection and expression
12/03/1997	EP0809510A1 LYMPHOTOXIN-$g(a)/$g(b) COMPLEXES AND ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS
12/03/1997	EP0809500A1 Novel glucocorticoid response elements
12/03/1997	EP0597852B1 Swine pneumonia vaccine and method for the preparation thereof
12/03/1997	CN1166858A The tagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
12/03/1997	CN1166838A Antibodies against allogenic and Xenogenic proteins, their use in diagnosis and therapy and methods for determination thereof
12/02/1997	US5693777 DNA encoding pasteurella haemolytica PhaI restriction endonuclease and methyltransterase
12/02/1997	US5693776 Nucleic acids specific for Rochalimaea quintana
12/02/1997	US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
12/02/1997	US5693764 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
12/02/1997	US5693763 Antibodies to human carcinoma antigen
12/02/1997	US5693762 Humanized immunoglobulins
12/02/1997	US5693761 Genetic engineering; complementarity zones
12/02/1997	US5693760 Specific amino acid sequence consisting of position 2-135 includes a glycosylation site within position 96-98, binds beta-glalactoside containing moieties independent of absence of presence of calcium ions, stimulates hemagglutination
12/02/1997	US5693755 Construction and expression of synthetic genes encoding envelopes of human T cell leukemia virus type I
12/02/1997	US5693753 Method of isolating βA4 peptide species ending at carboxy-terminals residue 42 using monoclonal antibody 369.2B
12/02/1997	US5693752 Hexapeptides of specified amino acid sequences
12/02/1997	US5693530 Recombinant vectors; vaccines
12/02/1997	US5693522 Anti-cancer immunotherapeutics
12/02/1997	US5693497 Incubation of genetically engineered cells for gene expression of antigen which can be used for vaccines or diagnosis
12/02/1997	US5693496 DNA encoding the mouse and human PH30 beta chain protein
12/02/1997	US5693495 Allergens of alder pollen and applications thereof
12/02/1997	US5693479 Obtaining trophoblast sample from conceptus prior to uterine implantation of the conceptus, administering transforming growth factor to sample, evaluating production by the sample of trophoblast fibronectin
12/02/1997	US5693472 Detecting dna of seq id no:1,2,3 or 4 by hybridization probing and/or nucleotide sequence amplification; testing samples of surface water or feces; vaccines

1 ... 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 ... 1823